1. Home
  2. GBIO vs EUDA Comparison

GBIO vs EUDA Comparison

Compare GBIO & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • EUDA
  • Stock Information
  • Founded
  • GBIO 2016
  • EUDA 2021
  • Country
  • GBIO United States
  • EUDA Singapore
  • Employees
  • GBIO N/A
  • EUDA N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • EUDA Blank Checks
  • Sector
  • GBIO Health Care
  • EUDA Finance
  • Exchange
  • GBIO Nasdaq
  • EUDA Nasdaq
  • Market Cap
  • GBIO 29.5M
  • EUDA 111.5M
  • IPO Year
  • GBIO 2020
  • EUDA N/A
  • Fundamental
  • Price
  • GBIO $5.85
  • EUDA $1.07
  • Analyst Decision
  • GBIO Buy
  • EUDA
  • Analyst Count
  • GBIO 4
  • EUDA 0
  • Target Price
  • GBIO $10.67
  • EUDA N/A
  • AVG Volume (30 Days)
  • GBIO 76.7K
  • EUDA 159.9K
  • Earning Date
  • GBIO 11-05-2025
  • EUDA 01-01-0001
  • Dividend Yield
  • GBIO N/A
  • EUDA N/A
  • EPS Growth
  • GBIO N/A
  • EUDA N/A
  • EPS
  • GBIO N/A
  • EUDA N/A
  • Revenue
  • GBIO $21,230,000.00
  • EUDA $4,011,005.00
  • Revenue This Year
  • GBIO N/A
  • EUDA $212.19
  • Revenue Next Year
  • GBIO N/A
  • EUDA $254.35
  • P/E Ratio
  • GBIO N/A
  • EUDA N/A
  • Revenue Growth
  • GBIO 61.15
  • EUDA 8.22
  • 52 Week Low
  • GBIO $3.00
  • EUDA $1.03
  • 52 Week High
  • GBIO $29.10
  • EUDA $6.30
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 51.93
  • EUDA 22.68
  • Support Level
  • GBIO $5.51
  • EUDA $1.03
  • Resistance Level
  • GBIO $6.04
  • EUDA $1.70
  • Average True Range (ATR)
  • GBIO 0.31
  • EUDA 0.21
  • MACD
  • GBIO -0.09
  • EUDA -0.03
  • Stochastic Oscillator
  • GBIO 45.27
  • EUDA 2.94

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.

Share on Social Networks: